Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Dextromethorphan Hydrobromide and Bupropion Hydrochloride ER Tablets in Adults With Major Depressive Disorder
CTR20253260Phase 3Completed
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dextromethorphan + bupropion in major depressive disorder (MDD), sponsored by Jiangsu Nhwa Pharmaceutical. Started Aug 2025; status: completed.
02
Drugs
dextromethorphan + bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20253260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253260.